chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: UNK, COVID19, COVID19
Symptoms: Confusional state, Death, Ejection fraction decreased, Fall, Head injury
Clinical narrative: 3/18/21  Patient is a 74-year-old man with a history of coronary artery disease who presents via ground EMS as a trauma 1.  Per reports, the patient was shopping when he suddenly lost consciousness resulting in him falling forward and striking his forehead.  En route, the patient's blood systolic blood pressure dropped to the 90's and he became more confused.  Primary survey was notable for an intact airway, bilateral breath sounds, weak femoral pulses, GCS 15.  Secondary survey is notable for abrasions of the forehead and cool/clammy extremities.  The patient's initial heart rate was in the 70s and systolic blood pressure in the 60s.  A chest x-ray was performed showing no significant abnormalities. FAST exam showed no free fluid in the abdomen, no pericardial tamponade, but severely/globally depressed cardiac function without discrete wall motion abnormalities.  Shortly after arrival patient lost pulses and was found to be in PEA arrest.  ACLS was initiated and CPR performed for approximately 16 minutes.  The patient was administered multiple doses of epinephrine, amiodarone, bicarb, and calcium.  A Cordis catheter was inserted into the right femoral vein and an arterial line into the left femoral artery.  Repeat evaluation revealed ventricular fibrillation for which multiple shocks were administered.  Return of spontaneous circulation was obtained but lost minutes later.  Ultimately, the patient was pronounced dead.
Age: 74.0
Sex: M
Vaccine: UNK, COVID19, COVID19
Symptoms: Loss of consciousness, Pulse abnormal, Pulse absent, Pulseless electrical activity, Resuscitation
Clinical narrative: 3/18/21  Patient is a 74-year-old man with a history of coronary artery disease who presents via ground EMS as a trauma 1.  Per reports, the patient was shopping when he suddenly lost consciousness resulting in him falling forward and striking his forehead.  En route, the patient's blood systolic blood pressure dropped to the 90's and he became more confused.  Primary survey was notable for an intact airway, bilateral breath sounds, weak femoral pulses, GCS 15.  Secondary survey is notable for abrasions of the forehead and cool/clammy extremities.  The patient's initial heart rate was in the 70s and systolic blood pressure in the 60s.  A chest x-ray was performed showing no significant abnormalities. FAST exam showed no free fluid in the abdomen, no pericardial tamponade, but severely/globally depressed cardiac function without discrete wall motion abnormalities.  Shortly after arrival patient lost pulses and was found to be in PEA arrest.  ACLS was initiated and CPR performed for approximately 16 minutes.  The patient was administered multiple doses of epinephrine, amiodarone, bicarb, and calcium.  A Cordis catheter was inserted into the right femoral vein and an arterial line into the left femoral artery.  Repeat evaluation revealed ventricular fibrillation for which multiple shocks were administered.  Return of spontaneous circulation was obtained but lost minutes later.  Ultimately, the patient was pronounced dead.
Age: 74.0
Sex: M
Vaccine: UNK, COVID19, COVID19
Symptoms: Skin abrasion, Ventricular fibrillation
Clinical narrative: 3/18/21  Patient is a 74-year-old man with a history of coronary artery disease who presents via ground EMS as a trauma 1.  Per reports, the patient was shopping when he suddenly lost consciousness resulting in him falling forward and striking his forehead.  En route, the patient's blood systolic blood pressure dropped to the 90's and he became more confused.  Primary survey was notable for an intact airway, bilateral breath sounds, weak femoral pulses, GCS 15.  Secondary survey is notable for abrasions of the forehead and cool/clammy extremities.  The patient's initial heart rate was in the 70s and systolic blood pressure in the 60s.  A chest x-ray was performed showing no significant abnormalities. FAST exam showed no free fluid in the abdomen, no pericardial tamponade, but severely/globally depressed cardiac function without discrete wall motion abnormalities.  Shortly after arrival patient lost pulses and was found to be in PEA arrest.  ACLS was initiated and CPR performed for approximately 16 minutes.  The patient was administered multiple doses of epinephrine, amiodarone, bicarb, and calcium.  A Cordis catheter was inserted into the right femoral vein and an arterial line into the left femoral artery.  Repeat evaluation revealed ventricular fibrillation for which multiple shocks were administered.  Return of spontaneous circulation was obtained but lost minutes later.  Ultimately, the patient was pronounced dead.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity
Clinical narrative: HORRIBLE HEADACHES; PAIN IN ARMS; NAUSEATED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, ethnic origin, race and medical history were not reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry date: not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow-up to request batch number. No concomitant medications were reported. On an unspecified date, the subject experienced headache, pain in arms, and nausea. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, pain in arms and nausea was not reported. This report was non-serious.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: feeling of closing of the throat. Pt came in for covid vaccine. Answered no to screening questions. Was given Janssen single dose. Pt asked MA, what an allergic reaction looks like. I stepped in and told pt. hives, swelling/ closing of the throat, and feeling like you can't breathe. Pt stated @ 1535 that she felt her throat was closing up a little and that breathing was getting difficult. Pt was speaking in clear full sentences w/o difficulty. I told her to take deep breathes and drink water. I assessed her, she was warm and dry and no apparent swelling of the throat, no itchiness or dryness of the throat. MA brought in BP machine, vital signs were stable. O2 was at 95%. Pt has asthma. I wanted to seek a second opinion on pts well-being, MA went to seek provider that had seen pt prior to vaccination. As MA went to get nurse, I continued to talk to pt about her status. I asked if the feeling was getting better or worse and pt said it was staying the same. Pt was not in distress and speaking in clear full sentences. I told her if her status worsens I have an epi pen to help her breathe better. MA came back 5 minutes later w/o provider  and pt stated her throat closing as she had her hands on her throat and was worried. MA did not realize the urgency of the situation and went back to get the nurse. During this time I asked pt if the feeling was getting worse and pt said yes. I told her I have the epi pen and thats when pt requested I administer it to her. I administered the epi pen at 1554. One minute later Nurse comes in to assess pt. Pt is calm and speaking in clear full sentences. MA takes vital signs and BP is elevated and O2 is at 99%. I inform the nurse that I administered epi and she advised to keep pt for observation, she left to see another pt. Pt was calm and speaking in clear full sentences A&O X4 and stated that the feeling was better. At 1610 Pt stated that her throat was feeling the same closing feeling as before the epi pen. I messaged my nurse supervisor, at 1612 about pt and she proceeded to bring Dr. for assessment. Dr.  assessed pt and told me to call 911. Pt was not in distress and speaking in clear full sentences. Fire dept. came and took over the situation approximately 8 minutes later. Pt requested to be taken to Hospital.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Pharyngeal swelling
Clinical narrative: feeling of closing of the throat. Pt came in for covid vaccine. Answered no to screening questions. Was given Janssen single dose. Pt asked MA, what an allergic reaction looks like. I stepped in and told pt. hives, swelling/ closing of the throat, and feeling like you can't breathe. Pt stated @ 1535 that she felt her throat was closing up a little and that breathing was getting difficult. Pt was speaking in clear full sentences w/o difficulty. I told her to take deep breathes and drink water. I assessed her, she was warm and dry and no apparent swelling of the throat, no itchiness or dryness of the throat. MA brought in BP machine, vital signs were stable. O2 was at 95%. Pt has asthma. I wanted to seek a second opinion on pts well-being, MA went to seek provider that had seen pt prior to vaccination. As MA went to get nurse, I continued to talk to pt about her status. I asked if the feeling was getting better or worse and pt said it was staying the same. Pt was not in distress and speaking in clear full sentences. I told her if her status worsens I have an epi pen to help her breathe better. MA came back 5 minutes later w/o provider  and pt stated her throat closing as she had her hands on her throat and was worried. MA did not realize the urgency of the situation and went back to get the nurse. During this time I asked pt if the feeling was getting worse and pt said yes. I told her I have the epi pen and thats when pt requested I administer it to her. I administered the epi pen at 1554. One minute later Nurse comes in to assess pt. Pt is calm and speaking in clear full sentences. MA takes vital signs and BP is elevated and O2 is at 99%. I inform the nurse that I administered epi and she advised to keep pt for observation, she left to see another pt. Pt was calm and speaking in clear full sentences A&O X4 and stated that the feeling was better. At 1610 Pt stated that her throat was feeling the same closing feeling as before the epi pen. I messaged my nurse supervisor, at 1612 about pt and she proceeded to bring Dr. for assessment. Dr.  assessed pt and told me to call 911. Pt was not in distress and speaking in clear full sentences. Fire dept. came and took over the situation approximately 8 minutes later. Pt requested to be taken to Hospital.
Age: 60.0
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling hot, Pain, Pruritus
Clinical narrative: TROUBLE BREATHING; SKIN ITCHES; FELT HEATED UP; MAJOR BODY ACHES; This spontaneous report received from a patient concerned a 60 year old of unspecified sex. The patient's weight was 30 pounds, and height was not reported. The patient's concurrent conditions included abstains from alcohol, and non-smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on left arm on 07-APR-2021 around 11:00 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021 18:00, the subject experienced trouble breathing. On 07-APR-2021 18:00, the subject experienced skin itches. On 07-APR-2021 18:00, the subject experienced feel heated up. On 07-APR-2021 18:00, the subject experienced major body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the trouble breathing, skin itches, feel heated up and major body aches was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Fatigue, Oral pain, Pain in extremity, Rash
Clinical narrative: MOUTH TENDERNESS; RIGHT ARM SORENESS; FATIGUE; SKIN RASH; THIN FILM OF BLOOD ON HER NOSE "SINUSES"; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included breast cancer.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and it has been requested. Non-company suspect drugs included: palbociclib (form of admin unknown, oral, batch number was not reported) 125 mg, 1 time every 1 day, from 12-FEB-2021 for breast cancer. Concomitant medications included letrozole. On 12-FEB-2021, the subject experienced thin film of blood on her nose "sinuses". On 12-FEB-2021, the subject experienced skin rash. On MAR-2021, the subject experienced right arm soreness. On MAR-2021, the subject experienced fatigue. Laboratory data included: Blood test (NR: not provided) low white blood cell count. On an unspecified date, the subject experienced mouth tenderness. Treatment medications (dates unspecified) included: sodium chloride, and hydrocortisone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from skin rash, and right arm soreness, and fatigue on MAR-2021, was recovering from thin film of blood on her nose "sinuses", and the outcome of mouth tenderness was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Sinus disorder
Clinical narrative: MOUTH TENDERNESS; RIGHT ARM SORENESS; FATIGUE; SKIN RASH; THIN FILM OF BLOOD ON HER NOSE "SINUSES"; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included breast cancer.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and it has been requested. Non-company suspect drugs included: palbociclib (form of admin unknown, oral, batch number was not reported) 125 mg, 1 time every 1 day, from 12-FEB-2021 for breast cancer. Concomitant medications included letrozole. On 12-FEB-2021, the subject experienced thin film of blood on her nose "sinuses". On 12-FEB-2021, the subject experienced skin rash. On MAR-2021, the subject experienced right arm soreness. On MAR-2021, the subject experienced fatigue. Laboratory data included: Blood test (NR: not provided) low white blood cell count. On an unspecified date, the subject experienced mouth tenderness. Treatment medications (dates unspecified) included: sodium chloride, and hydrocortisone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from skin rash, and right arm soreness, and fatigue on MAR-2021, was recovering from thin film of blood on her nose "sinuses", and the outcome of mouth tenderness was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Fatigue, Headache, Injection site pain, Limb discomfort
Clinical narrative: NECK HURTS BY HER SHOULDERS; ARMS BOTHERING; TIREDNESS; HEADACHE; NAUSEA; MUSCLE ACHES; INJECTION SITE PAIN; FEVER; PAIN IN RIGHT ARM; SEVERE NECK SWELLING; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included coronavirus infection, and concurrent conditions included tired. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: 23-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced severe neck swelling. On APR-2021, the subject experienced pain in right arm. On APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 98.6 F, 99.9 F, 101.5 F. On 07-APR-2021, the subject experienced neck hurts by her shoulders. On 07-APR-2021, the subject experienced arms bothering. On 07-APR-2021, the subject experienced tiredness. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced muscle aches. On 07-APR-2021, the subject experienced injection site pain. On 08-APR-2021, Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and injection site pain on APR-2021, had not recovered from tiredness, nausea, muscle aches, fever, arms bothering, and neck hurts by her shoulders, and the outcome of pain in right arm and severe neck swelling was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea, Neck pain, Pain in extremity, Pyrexia
Clinical narrative: NECK HURTS BY HER SHOULDERS; ARMS BOTHERING; TIREDNESS; HEADACHE; NAUSEA; MUSCLE ACHES; INJECTION SITE PAIN; FEVER; PAIN IN RIGHT ARM; SEVERE NECK SWELLING; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included coronavirus infection, and concurrent conditions included tired. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: 23-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced severe neck swelling. On APR-2021, the subject experienced pain in right arm. On APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 98.6 F, 99.9 F, 101.5 F. On 07-APR-2021, the subject experienced neck hurts by her shoulders. On 07-APR-2021, the subject experienced arms bothering. On 07-APR-2021, the subject experienced tiredness. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced muscle aches. On 07-APR-2021, the subject experienced injection site pain. On 08-APR-2021, Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and injection site pain on APR-2021, had not recovered from tiredness, nausea, muscle aches, fever, arms bothering, and neck hurts by her shoulders, and the outcome of pain in right arm and severe neck swelling was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling
Clinical narrative: NECK HURTS BY HER SHOULDERS; ARMS BOTHERING; TIREDNESS; HEADACHE; NAUSEA; MUSCLE ACHES; INJECTION SITE PAIN; FEVER; PAIN IN RIGHT ARM; SEVERE NECK SWELLING; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included coronavirus infection, and concurrent conditions included tired. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: 23-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced severe neck swelling. On APR-2021, the subject experienced pain in right arm. On APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 98.6 F, 99.9 F, 101.5 F. On 07-APR-2021, the subject experienced neck hurts by her shoulders. On 07-APR-2021, the subject experienced arms bothering. On 07-APR-2021, the subject experienced tiredness. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced muscle aches. On 07-APR-2021, the subject experienced injection site pain. On 08-APR-2021, Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and injection site pain on APR-2021, had not recovered from tiredness, nausea, muscle aches, fever, arms bothering, and neck hurts by her shoulders, and the outcome of pain in right arm and severe neck swelling was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Bedridden, Body temperature, Dizziness, Feeding disorder
Clinical narrative: NECK HURTS BY HER SHOULDERS; ARMS BOTHERING; TIREDNESS; HEADACHE; NAUSEA; MUSCLE ACHES; INJECTION SITE PAIN; FEVER; PAIN IN RIGHT ARM; SEVERE NECK SWELLING; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included coronavirus infection, and concurrent conditions included tired. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: 23-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced severe neck swelling. On APR-2021, the subject experienced pain in right arm. On APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 98.6 F, 99.9 F, 101.5 F. On 07-APR-2021, the subject experienced neck hurts by her shoulders. On 07-APR-2021, the subject experienced arms bothering. On 07-APR-2021, the subject experienced tiredness. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced muscle aches. On 07-APR-2021, the subject experienced injection site pain. On 08-APR-2021, Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and injection site pain on APR-2021, had not recovered from tiredness, nausea, muscle aches, fever, arms bothering, and neck hurts by her shoulders, and the outcome of pain in right arm and severe neck swelling was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Illness, Nausea, Pain, Pyrexia
Clinical narrative: NECK HURTS BY HER SHOULDERS; ARMS BOTHERING; TIREDNESS; HEADACHE; NAUSEA; MUSCLE ACHES; INJECTION SITE PAIN; FEVER; PAIN IN RIGHT ARM; SEVERE NECK SWELLING; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included coronavirus infection, and concurrent conditions included tired. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: 23-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced severe neck swelling. On APR-2021, the subject experienced pain in right arm. On APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 98.6 F, 99.9 F, 101.5 F. On 07-APR-2021, the subject experienced neck hurts by her shoulders. On 07-APR-2021, the subject experienced arms bothering. On 07-APR-2021, the subject experienced tiredness. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced muscle aches. On 07-APR-2021, the subject experienced injection site pain. On 08-APR-2021, Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and injection site pain on APR-2021, had not recovered from tiredness, nausea, muscle aches, fever, arms bothering, and neck hurts by her shoulders, and the outcome of pain in right arm and severe neck swelling was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Somnolence
Clinical narrative: NECK HURTS BY HER SHOULDERS; ARMS BOTHERING; TIREDNESS; HEADACHE; NAUSEA; MUSCLE ACHES; INJECTION SITE PAIN; FEVER; PAIN IN RIGHT ARM; SEVERE NECK SWELLING; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included coronavirus infection, and concurrent conditions included tired. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: 23-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced severe neck swelling. On APR-2021, the subject experienced pain in right arm. On APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 98.6 F, 99.9 F, 101.5 F. On 07-APR-2021, the subject experienced neck hurts by her shoulders. On 07-APR-2021, the subject experienced arms bothering. On 07-APR-2021, the subject experienced tiredness. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced muscle aches. On 07-APR-2021, the subject experienced injection site pain. On 08-APR-2021, Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and injection site pain on APR-2021, had not recovered from tiredness, nausea, muscle aches, fever, arms bothering, and neck hurts by her shoulders, and the outcome of pain in right arm and severe neck swelling was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Fatigue, Headache, Injection site pain, Limb discomfort
Clinical narrative: UNABLE TO EAT OR DRINK; PAIN IN THE BODY (NECK & RIGHT ARM/SHOULDER); DIZZINESS; SICK; FEELING LOUSY; DIDN'T WANT TO GET OUT OF BED; WANTED TO SLEEP; FEVER; NAUSEA; FELT WEAK; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 202A21A and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 10:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 99 F. On 07-APR-2021, the subject experienced unable to eat or drink. On 07-APR-2021, the subject experienced pain in the body (neck & right arm/shoulder). On 07-APR-2021, the subject experienced dizziness. On 07-APR-2021, the subject experienced sick. On 07-APR-2021, the subject experienced lousy. On 07-APR-2021, the subject experienced didn't want to get out of bed. On 07-APR-2021, the subject experienced wanted to sleep. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced felt weak. On 08-APR-2021 18:50, Laboratory data included: Body temperature (NR: not provided) 101.5 F. On 09-APR-2021, Laboratory data included: Body temperature (NR: not provided) 100.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain in the body (neck & right arm/shoulder), fever, nausea, dizziness, sick, lousy, felt weak, didn't want to get out of bed, unable to eat or drink and wanted to sleep was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea, Neck pain, Pain in extremity, Pyrexia
Clinical narrative: UNABLE TO EAT OR DRINK; PAIN IN THE BODY (NECK & RIGHT ARM/SHOULDER); DIZZINESS; SICK; FEELING LOUSY; DIDN'T WANT TO GET OUT OF BED; WANTED TO SLEEP; FEVER; NAUSEA; FELT WEAK; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 202A21A and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 10:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 99 F. On 07-APR-2021, the subject experienced unable to eat or drink. On 07-APR-2021, the subject experienced pain in the body (neck & right arm/shoulder). On 07-APR-2021, the subject experienced dizziness. On 07-APR-2021, the subject experienced sick. On 07-APR-2021, the subject experienced lousy. On 07-APR-2021, the subject experienced didn't want to get out of bed. On 07-APR-2021, the subject experienced wanted to sleep. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced felt weak. On 08-APR-2021 18:50, Laboratory data included: Body temperature (NR: not provided) 101.5 F. On 09-APR-2021, Laboratory data included: Body temperature (NR: not provided) 100.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain in the body (neck & right arm/shoulder), fever, nausea, dizziness, sick, lousy, felt weak, didn't want to get out of bed, unable to eat or drink and wanted to sleep was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling
Clinical narrative: UNABLE TO EAT OR DRINK; PAIN IN THE BODY (NECK & RIGHT ARM/SHOULDER); DIZZINESS; SICK; FEELING LOUSY; DIDN'T WANT TO GET OUT OF BED; WANTED TO SLEEP; FEVER; NAUSEA; FELT WEAK; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 202A21A and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 10:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 99 F. On 07-APR-2021, the subject experienced unable to eat or drink. On 07-APR-2021, the subject experienced pain in the body (neck & right arm/shoulder). On 07-APR-2021, the subject experienced dizziness. On 07-APR-2021, the subject experienced sick. On 07-APR-2021, the subject experienced lousy. On 07-APR-2021, the subject experienced didn't want to get out of bed. On 07-APR-2021, the subject experienced wanted to sleep. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced felt weak. On 08-APR-2021 18:50, Laboratory data included: Body temperature (NR: not provided) 101.5 F. On 09-APR-2021, Laboratory data included: Body temperature (NR: not provided) 100.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain in the body (neck & right arm/shoulder), fever, nausea, dizziness, sick, lousy, felt weak, didn't want to get out of bed, unable to eat or drink and wanted to sleep was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Bedridden, Body temperature, Dizziness, Feeding disorder
Clinical narrative: UNABLE TO EAT OR DRINK; PAIN IN THE BODY (NECK & RIGHT ARM/SHOULDER); DIZZINESS; SICK; FEELING LOUSY; DIDN'T WANT TO GET OUT OF BED; WANTED TO SLEEP; FEVER; NAUSEA; FELT WEAK; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 202A21A and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 10:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 99 F. On 07-APR-2021, the subject experienced unable to eat or drink. On 07-APR-2021, the subject experienced pain in the body (neck & right arm/shoulder). On 07-APR-2021, the subject experienced dizziness. On 07-APR-2021, the subject experienced sick. On 07-APR-2021, the subject experienced lousy. On 07-APR-2021, the subject experienced didn't want to get out of bed. On 07-APR-2021, the subject experienced wanted to sleep. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced felt weak. On 08-APR-2021 18:50, Laboratory data included: Body temperature (NR: not provided) 101.5 F. On 09-APR-2021, Laboratory data included: Body temperature (NR: not provided) 100.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain in the body (neck & right arm/shoulder), fever, nausea, dizziness, sick, lousy, felt weak, didn't want to get out of bed, unable to eat or drink and wanted to sleep was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Illness, Nausea, Pain, Pyrexia
Clinical narrative: UNABLE TO EAT OR DRINK; PAIN IN THE BODY (NECK & RIGHT ARM/SHOULDER); DIZZINESS; SICK; FEELING LOUSY; DIDN'T WANT TO GET OUT OF BED; WANTED TO SLEEP; FEVER; NAUSEA; FELT WEAK; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 202A21A and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 10:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 99 F. On 07-APR-2021, the subject experienced unable to eat or drink. On 07-APR-2021, the subject experienced pain in the body (neck & right arm/shoulder). On 07-APR-2021, the subject experienced dizziness. On 07-APR-2021, the subject experienced sick. On 07-APR-2021, the subject experienced lousy. On 07-APR-2021, the subject experienced didn't want to get out of bed. On 07-APR-2021, the subject experienced wanted to sleep. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced felt weak. On 08-APR-2021 18:50, Laboratory data included: Body temperature (NR: not provided) 101.5 F. On 09-APR-2021, Laboratory data included: Body temperature (NR: not provided) 100.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain in the body (neck & right arm/shoulder), fever, nausea, dizziness, sick, lousy, felt weak, didn't want to get out of bed, unable to eat or drink and wanted to sleep was not reported. This report was non-serious.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Somnolence
Clinical narrative: UNABLE TO EAT OR DRINK; PAIN IN THE BODY (NECK & RIGHT ARM/SHOULDER); DIZZINESS; SICK; FEELING LOUSY; DIDN'T WANT TO GET OUT OF BED; WANTED TO SLEEP; FEVER; NAUSEA; FELT WEAK; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 202A21A and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 10:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 99 F. On 07-APR-2021, the subject experienced unable to eat or drink. On 07-APR-2021, the subject experienced pain in the body (neck & right arm/shoulder). On 07-APR-2021, the subject experienced dizziness. On 07-APR-2021, the subject experienced sick. On 07-APR-2021, the subject experienced lousy. On 07-APR-2021, the subject experienced didn't want to get out of bed. On 07-APR-2021, the subject experienced wanted to sleep. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced felt weak. On 08-APR-2021 18:50, Laboratory data included: Body temperature (NR: not provided) 101.5 F. On 09-APR-2021, Laboratory data included: Body temperature (NR: not provided) 100.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain in the body (neck & right arm/shoulder), fever, nausea, dizziness, sick, lousy, felt weak, didn't want to get out of bed, unable to eat or drink and wanted to sleep was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Muscle contracture, Nausea, Pyrexia
Clinical narrative: JOINT PAIN; HEADACHE; NAUSEA; FEVER; TREMORS/ UNCONTROLLED SHAKING; JAW CLENCHING; This spontaneous report received from a patient concerned a 22 year old male. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 14:30 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced jaw clenching. On 07-APR-2021 19:30, the subject experienced tremors/ uncontrolled shaking. On 07-APR-2021 19:30, the subject experienced fever. On 07-APR-2021 20:00, the subject experienced nausea. On 07-APR-2021 23:00, the subject experienced joint pain. On 07-APR-2021 23:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tremors/ uncontrolled shaking, and jaw clenching, and had not recovered from headache, nausea, joint pain, and fever. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: JOINT PAIN; HEADACHE; NAUSEA; FEVER; TREMORS/ UNCONTROLLED SHAKING; JAW CLENCHING; This spontaneous report received from a patient concerned a 22 year old male. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 14:30 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced jaw clenching. On 07-APR-2021 19:30, the subject experienced tremors/ uncontrolled shaking. On 07-APR-2021 19:30, the subject experienced fever. On 07-APR-2021 20:00, the subject experienced nausea. On 07-APR-2021 23:00, the subject experienced joint pain. On 07-APR-2021 23:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tremors/ uncontrolled shaking, and jaw clenching, and had not recovered from headache, nausea, joint pain, and fever. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: UNSPECIFIED ADVERSE EVENT; This spontaneous report received from a patient by a partner on 06-APR-2021 was received on 06-APR-2021 and concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination.   Batch number was not reported. The company was unable to perform follow up to request batch number. No concomitant medications were reported. On an unspecified date, the subject experienced unspecified adverse event. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unspecified adverse event was not reported. This report was non-serious.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypoaesthesia, Nausea, Pain
Clinical narrative: NAUSEA; FATIGUE; BODY ACHES; TINGLING IN EXTREMITIES; NUMBNESS OF EXTREMITIES; DULL HEADACHE; This spontaneous report received from a patient concerned a 32 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, and batch number: 1802068 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 on left deltoid for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced body aches. On 01-APR-2021, the subject experienced tingling in extremities. On 01-APR-2021, the subject experienced numbness of extremities. On 01-APR-2021, the subject experienced dull headache. On 06-APR-2021, the subject experienced nausea. On 06-APR-2021, the subject experienced fatigue. Treatment medications included: ibuprofen, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dull headache on 03-APR-2021, and had not recovered from body aches, tingling in extremities, numbness of extremities, nausea, and fatigue. This report was non-serious.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: NAUSEA; FATIGUE; BODY ACHES; TINGLING IN EXTREMITIES; NUMBNESS OF EXTREMITIES; DULL HEADACHE; This spontaneous report received from a patient concerned a 32 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, and batch number: 1802068 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 on left deltoid for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced body aches. On 01-APR-2021, the subject experienced tingling in extremities. On 01-APR-2021, the subject experienced numbness of extremities. On 01-APR-2021, the subject experienced dull headache. On 06-APR-2021, the subject experienced nausea. On 06-APR-2021, the subject experienced fatigue. Treatment medications included: ibuprofen, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dull headache on 03-APR-2021, and had not recovered from body aches, tingling in extremities, numbness of extremities, nausea, and fatigue. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: ARM SORENESS; HEADACHE; This spontaneous report received from a patient concerned a 59 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 to left deltoid for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced arm soreness. On 07-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, and arm soreness. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain lower, Body temperature, Chills, Headache, Nausea
Clinical narrative: SEVERE CHILLS; FEVER; HEADACHE; BODY ACHE; LOWER GI CRAMPING; VERTIGO; NAUSEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 043A21A, expiry: not reported) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced lower gi cramping. On APR-2021, the subject experienced vertigo. On APR-2021, the subject experienced nausea. On 05-APR-2021, the subject experienced body ache. On 05-APR-2021, the subject experienced severe chills. On 05-APR-2021, the subject experienced fever. On 05-APR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 102.4 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, severe chills, fever, and headache on APR-2021, and was recovering from nausea, lower gi cramping, and vertigo. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vertigo
Clinical narrative: SEVERE CHILLS; FEVER; HEADACHE; BODY ACHE; LOWER GI CRAMPING; VERTIGO; NAUSEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 043A21A, expiry: not reported) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced lower gi cramping. On APR-2021, the subject experienced vertigo. On APR-2021, the subject experienced nausea. On 05-APR-2021, the subject experienced body ache. On 05-APR-2021, the subject experienced severe chills. On 05-APR-2021, the subject experienced fever. On 05-APR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 102.4 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, severe chills, fever, and headache on APR-2021, and was recovering from nausea, lower gi cramping, and vertigo. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: LITTLE SORENESS; FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to follow up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced little soreness, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the little soreness and fever was not reported. This report was non-serious.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: TIREDNESS; This spontaneous report received from a consumer concerned a 67 year old male. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 07-APR-2021 to left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-APR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tiredness. This report was non-serious.